A randomized controlled trial on medication-overuse headache: outcome after 1 and 4 years
Authors:
- 28 June 2011
- journal article
- research article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 124 (s191) , 38-43
Abstract
Different opinions exist regarding the optimal treatment of patients with medication-overuse headache (MOH). Few studies have evaluated the long-term prognosis among these patients, and there are no standard measures of outcome in such studies. To summarize the 1- and 4-year outcome of patients with MOH previously included in a randomized follow-up study. Sixty-one patients with MOH were randomly assigned to receive either preventive treatment from day 1 without detoxification, a standard out patient detoxification program without preventive treatment from day 1, or no specific treatment. Sixty patients still alive were invited to a 4-year follow-up, whereof 50 (83%) participated. Early introduction of preventive treatment effectively reduced headache days and in particular headache suffering both during the first months and at 12-month follow-up. At 4-year follow-up, 16 persons (32%) were considered as responders (i.e. ≥50% reduction in headache frequency from baseline), whereas 17 persons (34%) met the criteria for MOH. None of the baseline characteristics consistently influenced all five outcome measures. Early introduction of prophylactic medication was an effective way to reduce headache days during the first 3 months, and the notion that patients with MOH need withdrawal of analgesics to respond to preventive medication seems to be incorrect. The long-term prognosis during the 4-year follow-up was relatively favorable as there was a steady decline in headache, one-third of the patients with MOH having ≥50% reduction in headache frequency from baseline and two-thirds being without medication overuse.Keywords
This publication has 26 references indexed in Scilit:
- A 4-year follow-up of patients with medication-overuse headache previously included in a randomized multicentre studyThe Journal of Headache and Pain, 2011
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical ProgramHeadache: The Journal of Head and Face Pain, 2010
- Medication overuse headache: a critical review of end points in recent follow-up studiesThe Journal of Headache and Pain, 2010
- A narrative review on the management of medication overuse headache: the steep road from experience to evidenceThe Journal of Headache and Pain, 2009
- Management of Medication Overuse Headache: 1-Year Randomized Multicentre Open-Label TrialCephalalgia, 2009
- Topiramate Reduces Headache Days in Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled StudyCephalalgia, 2007
- Probable medication-overuse headacheNeurology, 2006
- New Appendix Criteria Open for a Broader Concept of Chronic MigraineCephalalgia, 2006
- The International Classification of Headache Disorders, 2nd Edition (ICHD-II)—-Revision of Criteria for 8.2 Medication-Overuse HeadacheCephalalgia, 2005
- Medication-overuse headache: a worldwide problemThe Lancet Neurology, 2004